AAAAAA

   
Results: 1-13 |
Results: 13
CONCENTRATION OF ENDOGENOUS TPA ANTIGEN IN CORONARY-ARTERY DISEASE - RELATION TO THROMBOTIC EVENTS, ASPIRIN TREATMENT, HYPERLIPIDEMIA, AND MULTIVESSEL DISEASE
Authors: GEPPERT A GRAF S BECKMANN R HORNYKEWYCZ S SCHUSTER E BINDER BR HUBER K
Citation: A. Geppert et al., CONCENTRATION OF ENDOGENOUS TPA ANTIGEN IN CORONARY-ARTERY DISEASE - RELATION TO THROMBOTIC EVENTS, ASPIRIN TREATMENT, HYPERLIPIDEMIA, AND MULTIVESSEL DISEASE, Arteriosclerosis, thrombosis, and vascular biology, 18(10), 1998, pp. 1634-1642
PERFORMANCE EVALUATION OF OBJECT-ORIENTED ACTIVE DATABASE-SYSTEMS USING THE BEAST BENCHMARK
Authors: GEPPERT A BERNDTSSON M LIEUWEN D RONCANCIO C
Citation: A. Geppert et al., PERFORMANCE EVALUATION OF OBJECT-ORIENTED ACTIVE DATABASE-SYSTEMS USING THE BEAST BENCHMARK, Theory and practice of object systems, 4(3), 1998, pp. 135-149
DEFINING THE SEMANTICS OF REACTIVE COMPONENTS IN EVENT-DRIVEN WORKFLOW EXECUTION WITH EVENT HISTORIES
Authors: GEPPERT A TOMBROS D DITTRICH KR
Citation: A. Geppert et al., DEFINING THE SEMANTICS OF REACTIVE COMPONENTS IN EVENT-DRIVEN WORKFLOW EXECUTION WITH EVENT HISTORIES, Information systems (Oxford), 23(3-4), 1998, pp. 235-252
THE 3RD INTERNATIONAL WORKSHOP ON RULES IN DATABASE-SYSTEMS (RIDS97)
Authors: GEPPERT A BERNDTSSON M
Citation: A. Geppert et M. Berndtsson, THE 3RD INTERNATIONAL WORKSHOP ON RULES IN DATABASE-SYSTEMS (RIDS97), Knowledge engineering review, 13(2), 1998, pp. 195-199
EXTENSIVE NECROTIZING FASCIITIS IN A DIABETIC PATIENT
Authors: MUNDIGLER G GEPPERT A HENK C GIRSCH W SIOSTRZONEK P
Citation: G. Mundigler et al., EXTENSIVE NECROTIZING FASCIITIS IN A DIABETIC PATIENT, Wiener Klinische Wochenschrift, 110(12), 1998, pp. 446-448
PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) AND CIRCULATING ADHESION MOLECULES IN PATIENTS WITH CARDIOGENIC-SHOCK - RELATION TO 48H-SURVIVAL
Authors: GEPPERT A ZORN G HUBER K SIOSTRZONEK P
Citation: A. Geppert et al., PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) AND CIRCULATING ADHESION MOLECULES IN PATIENTS WITH CARDIOGENIC-SHOCK - RELATION TO 48H-SURVIVAL, Thrombosis and haemostasis, 1997, pp. 590-590
CARDIOPULMONARY-RESUSCITATION TRAINING - A MUST FOR ALL EMPLOYEES
Authors: RAUSCHA F SCHNEIDER S GEPPERT A DOMANOVITS H HRSKA F LAGGNER A WEBER H MAUER G
Citation: F. Rauscha et al., CARDIOPULMONARY-RESUSCITATION TRAINING - A MUST FOR ALL EMPLOYEES, Circulation, 94(8), 1996, pp. 2080-2080
EFFECTS OF INTRAAORTIC BALLOON PUMPING ON CORONARY AND CAROTID FLOW DURING PERCUTANEOUS CARDIOPULMONARY SUPPORT
Authors: GEPPERT A FREY B GABRIEL H KRATOCHWILL C SIOSTRZONEK P
Citation: A. Geppert et al., EFFECTS OF INTRAAORTIC BALLOON PUMPING ON CORONARY AND CAROTID FLOW DURING PERCUTANEOUS CARDIOPULMONARY SUPPORT, The Annals of thoracic surgery, 61(5), 1996, pp. 1539-1541
LABORATORY MONITORING OF SUCCESS AND FAILURE OF THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION
Authors: HUBER K HORNYKEWYCZ S GRAF S GABRIEL H GEPPERT A
Citation: K. Huber et al., LABORATORY MONITORING OF SUCCESS AND FAILURE OF THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION, Fibrinolysis, 9, 1995, pp. 53-57
TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR IN PATIENTS WITH CORONARY-ARTERY DISEASE - RELATIONS TO CLINICAL-VARIABLES AND CARDIOVASCULAR RISK-FACTORS
Authors: GEPPERT A BECKMANN R GRAF S HORNYKEWYCZ S LANG I SCHUSTER E BINDER BR HUBER K
Citation: A. Geppert et al., TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR IN PATIENTS WITH CORONARY-ARTERY DISEASE - RELATIONS TO CLINICAL-VARIABLES AND CARDIOVASCULAR RISK-FACTORS, Fibrinolysis, 9, 1995, pp. 109-113
IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR DYSFUNCTION AFTER CORONARY-ARTERY BYPASS-GRAFTING
Authors: GEPPERT A BANKIER AA MAURER G STEFENELLI T
Citation: A. Geppert et al., IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR DYSFUNCTION AFTER CORONARY-ARTERY BYPASS-GRAFTING, The American journal of cardiology, 76(10), 1995, pp. 742
TISSUE-TYPE PLASMINOGEN-ACTIVATOR (TPA) LEVELS IN PATIENTS WITH CORONARY-ARTERY DISEASE (CAD) - CORRELATION WITH CLINICAL SEVERITY AND MEDICAL THERAPY
Authors: GEPPERT A BECKMANN R GRAF S HORNYKEWYCZ S BINDER BR HUBER K
Citation: A. Geppert et al., TISSUE-TYPE PLASMINOGEN-ACTIVATOR (TPA) LEVELS IN PATIENTS WITH CORONARY-ARTERY DISEASE (CAD) - CORRELATION WITH CLINICAL SEVERITY AND MEDICAL THERAPY, Circulation, 90(4), 1994, pp. 553-553
TISSUE-TYPE PLASMINOGEN-ACTIVATOR (TPA) LEVELS IN PATIENTS WITH CORONARY-ARTERY DISEASE (CAD) - CORRELATION WITH CLINICAL SEVERITY AND MEDICAL THERAPY
Authors: GEPPERT A BECKMANN R GRAF S HORNYKEWYCZ S BINDER BR HUBER K
Citation: A. Geppert et al., TISSUE-TYPE PLASMINOGEN-ACTIVATOR (TPA) LEVELS IN PATIENTS WITH CORONARY-ARTERY DISEASE (CAD) - CORRELATION WITH CLINICAL SEVERITY AND MEDICAL THERAPY, Circulation, 90(4), 1994, pp. 553-553
Risultati: 1-13 |